NPI: 1932353950 · GLENDALE, AZ 85302 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 11/05/2008
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 11/05/2008 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 26,890 | $783K |
| 2019 | 27,509 | $731K |
| 2020 | 27,445 | $844K |
| 2021 | 26,273 | $809K |
| 2022 | 25,538 | $895K |
| 2023 | 16,740 | $963K |
| 2024 | 8,578 | $752K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 57,697 | 4,733 | $5.45M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 720 | 415 | $306K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 33,473 | 2,611 | $15K |
| J1756 | Injection, iron sucrose, 1 mg | 9,838 | 2,531 | $1K |
| A4657 | Syringe, with or without needle, each | 17,252 | 3,100 | $83.72 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 526 | 458 | $0.00 |
| 82728 | 1,599 | 1,355 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 426 | 142 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 166 | 132 | $0.00 |
| 83550 | 1,575 | 1,328 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 26,333 | 2,152 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 155 | 139 | $0.00 |
| 90674 | 140 | 119 | $0.00 | |
| 83540 | 1,609 | 1,356 | $0.00 | |
| 85041 | 1,506 | 1,289 | $0.00 | |
| 85048 | 1,495 | 1,281 | $0.00 | |
| 82108 | 134 | 117 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 536 | 151 | $0.00 |
| 83970 | 1,123 | 963 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 2,653 | 231 | $0.00 |
| 90662 | 17 | 14 | $0.00 |